Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 2
1970 3
1973 1
1974 1
1977 6
1978 6
1979 2
1980 3
1981 5
1982 4
1983 3
1984 7
1985 6
1986 12
1987 5
1988 3
1989 8
1990 8
1991 9
1992 4
1993 2
1994 3
1996 4
1997 2
1998 2
1999 2
2000 1
2005 1
2011 2
2015 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
Williams RL, Clark T, Blume CD. Williams RL, et al. Am J Med. 1984 Nov 5;77(5A):62-6. doi: 10.1016/s0002-9343(84)80010-8. Am J Med. 1984. PMID: 6388328 Clinical Trial.
The results of an investigation to assess the clinical responses of patients with mild to moderate hypertension to a new combination formulation containing 75 mg triamterene and 50 mg hydrochlorothiazide are reported. One hundred fifty-six subjects entered the inves …
The results of an investigation to assess the clinical responses of patients with mild to moderate hypertension to a new combination formula …
Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.
Möhrke W, Knauf H, Mutschler E. Möhrke W, et al. Int J Clin Pharmacol Ther. 1997 Oct;35(10):447-52. Int J Clin Pharmacol Ther. 1997. PMID: 9352394 Clinical Trial.
Moreover, although triamterene is mostly applied concomitantly with thiazide-type diuretics the interaction of triamterene (TA) with hydrochlorothiazide (HCT) is subject to a controversial discussion. Therefore, the aim of this study was to examine the dose l …
Moreover, although triamterene is mostly applied concomitantly with thiazide-type diuretics the interaction of triamterene (TA …
Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
Maxwell MH, Brachfeld J, Itskovitz H, Lunn JA, Moser M, Zawada ET. Maxwell MH, et al. Clin Pharmacol Ther. 1985 Jan;37(1):61-5. doi: 10.1038/clpt.1985.12. Clin Pharmacol Ther. 1985. PMID: 3880686 Clinical Trial.
Five subjects receiving amiloride-hydrochlorothiazide (12%) and two subjects receiving triamterene-hydrochlorothiazide (5%) had hypokalemia (serum potassium level less than 3.5 mEq/l) at week 9. ...Serum magnesium levels were not changed by either regimen. We …
Five subjects receiving amiloride-hydrochlorothiazide (12%) and two subjects receiving triamterene-hydrochlorothiazide
A double-blind, placebo-controlled trial on the antihypertensive treatment effect of a quadruple single-pill combination.
Hu LX, Wang D, Liu HL, Zhang QT, Sun DS, Zhang L, Chen X, Chang GL, Wang JG. Hu LX, et al. J Clin Hypertens (Greenwich). 2021 Apr;23(4):815-822. doi: 10.1111/jch.14207. Epub 2021 Feb 6. J Clin Hypertens (Greenwich). 2021. PMID: 33548084 Free PMC article. Clinical Trial.
In a randomized, double-blind, placebo-controlled trial, we investigated antihypertensive treatment effect of a quadruple single-pill combination of reserpine 0.1 mg, dihydralazine 12.5 mg, hydrochlorothiazide 12.5 mg, and triamterene 12.5 mg, and changes in plasma …
In a randomized, double-blind, placebo-controlled trial, we investigated antihypertensive treatment effect of a quadruple single-pill combin …
Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension.
Heesen WF, Beltman FW, Smit AJ, May JF, de Graeff PA, Havinga TK, Schuurman FH, van der Veur E, Meyboom-de Jong B, Lie KI. Heesen WF, et al. J Cardiovasc Pharmacol. 1998 Feb;31(2):187-94. doi: 10.1097/00005344-199802000-00003. J Cardiovasc Pharmacol. 1998. PMID: 9475259 Clinical Trial.
We compared, in a prospective double-blind randomized study, the effect of the angiotensin-converting enzyme inhibitor quinapril (QUI) with that of triamterene/hydrochlorothiazide (THCT) treatment on cardiovascular end-organ damage in subjects with untreated isolate …
We compared, in a prospective double-blind randomized study, the effect of the angiotensin-converting enzyme inhibitor quinapril (QUI) with …
Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET Jr. Zawada ET Jr. Arch Intern Med. 1986 Jul;146(7):1312-4. Arch Intern Med. 1986. PMID: 3521523 Clinical Trial.
Eight subjects treated for four weeks with triamterene-hydrochlorothiazide were compared with nine patients similarly treated with amiloride-hydrochlorothiazide. ...It is concluded from these studies that therapy with amiloride-hydrochlorothiazide enha …
Eight subjects treated for four weeks with triamterene-hydrochlorothiazide were compared with nine patients similarly treated …
A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
Woo J, Woo KS, Kin T, Vallance-Owen J. Woo J, et al. Arch Intern Med. 1987 Aug;147(8):1386-9. Arch Intern Med. 1987. PMID: 2820329 Clinical Trial.
Two patients on triamterene and hydrochlorothiazide therapy withdrew because of side effects, while only minor side effects were observed with captopril therapy. Therapy with triamterene and hydrochlorothiazide produced significant elevation of urea, c …
Two patients on triamterene and hydrochlorothiazide therapy withdrew because of side effects, while only minor side effects we …
Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazide.
Spence JD, Wong DG, Lindsay RM. Spence JD, et al. Lancet. 1985 Jul 13;2(8446):73-5. doi: 10.1016/s0140-6736(85)90180-1. Lancet. 1985. PMID: 2861527 Clinical Trial.
Each drug was given for one month and all patients also received hydrochlorothiazide (50 mg/day). An abnormal urinary sediment--evident grossly as a reddish-brown precipitate after routine staining procedures and microscopically as characteristic reddish-brown crystals and …
Each drug was given for one month and all patients also received hydrochlorothiazide (50 mg/day). An abnormal urinary sediment--evide …
Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
Sharoky M, Perkal M, Tabatznik B, Cane RC Jr, Costello K, Goodwin P. Sharoky M, et al. Clin Pharm. 1989 Jul;8(7):496-500. Clin Pharm. 1989. PMID: 2752698 Clinical Trial.
The clinical efficacy, safety, and bioavailability of a generic triamterene-hydrochlorothiazide product were compared with those of Dyazide. ...Patients treated with a brand-name fixed-combination product containing triamterene 50 mg and hydrochlorothiazid
The clinical efficacy, safety, and bioavailability of a generic triamterene-hydrochlorothiazide product were compared with tho …
121 results